Trust President and CEO Mary Jane Rynd announces retirement, and Trustees name incoming CEO and new Board members PHOENIX--(BUSINESS WIRE)--The Board of Trustees of Virginia G. Piper Charitable Trust ...
PHOENIX--(BUSINESS WIRE)--Trustees of Virginia G. Piper Charitable Trust today awarded a total of $123 million in surprise grants to 71 Arizona nonprofits—the largest single-day grant initiative in ...
PHOENIX, June 09, 2026--(BUSINESS WIRE)--Virginia G. Piper Charitable Trust awarded nearly $25 million in grants during its recently concluded 2026 fiscal year, supporting local nonprofits and ...
One of Arizona’s largest philanthropic organizations, the Virginia G. Piper Charitable Trust, has named local charity veteran Steve Zabilski as its new president and CEO. Zabilski, who has led the ...
SCOTTSDALE, Ariz., Aug. 29, 2012 /PRNewswire-USNewswire/ -- A Phase I/II, multi-center trial designed to test the safety and preliminary efficacy of a first-in-class cancer treatment opened worldwide ...
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale ...
SCOTTSDALE, Ariz. -- Patients at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare were the first in the nation to participate in a clinical trial to determine the safety, ...
SCOTTSDALE, Ariz. — July 20, 2011 — A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results